DMX 200 doubles the proteinurea reduction on the current...

DMX 200 doubles the proteinurea reduction on the current standard of care medication and some make it out to be insignificant? We have multiple pharma and their experts examine all the data and they don't agree with the arm chair Google scientists. 2 deals signed and more in the works with some in the late stages of DD a deal could land anytime. We are also nearing the 144 recruitment target another key milestone reached. Reading pass announcements indications are the longer a patient is on DMX 200 greater the +ve affect it has on kidney function these Phase 3 trail patients will be on DMX 200 much longer than those of Phase 2 where in a short time significant results were reported just maybe we are on a winner.